Left Ventricular Hypertrophy Revisited: Cell and Matrix Expansion Have Disease-Specific Relationships

Circulation. 2017 Dec 19;136(25):2519-2521. doi: 10.1161/CIRCULATIONAHA.117.029895.

Authors

Thomas A Treibel^{1

2}, Rebecca Kozor³, Katia Menacho¹, Silvia Castelletti¹, Heerajnarain Bulluck², Stefania Rosmini^{1

2}, Sabrina Nordin^{1

2}, Viviana Maestrini¹, Marianna Fontana², James C Moon^{4

2}

Affiliations

¹ Barts Heart Centre, St Bartholomew's Hospital, London, UK (T.A.T., K.M., S.C., S.R., S.N., V.M., J.C.M.).
² Institute for Cardiovascular Sciences, University College London, UK (T.A.T., H.B., S.R., S.N., M.F., J.C.M.).
³ Sydney Medical School, University of Sydney, Australia (R.K.).
⁴ Barts Heart Centre, St Bartholomew's Hospital, London, UK (T.A.T., K.M., S.C., S.R., S.N., V.M., J.C.M.) james.moon@bartshealth.nhs.uk.

PMID: 29255128
DOI: 10.1161/CIRCULATIONAHA.117.029895

No abstract available

Keywords: T1 mapping; extracellular volume fraction; left ventricular hypertrophy.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Case-Control Studies
Cell Size*
Extracellular Matrix / pathology*
Female
Fibrosis
Humans
Hypertrophy, Left Ventricular / diagnostic imaging*
Hypertrophy, Left Ventricular / pathology
Hypertrophy, Left Ventricular / physiopathology
Magnetic Resonance Imaging*
Male
Middle Aged
Predictive Value of Tests
Ventricular Function, Left*
Ventricular Remodeling*

Grants and funding